The Future of Phlebology in Europe

Phlebology

Volumn 29, Issue S1, 2014, Pages 181-185

  Dharmarajah, Brahman ^a   Lane, Tristan RA ^a   Moore, Hayley M ^a   Neumann, HA Martino ^b   Rabe, Eberhard ^c   Wittens, Cees HA ^d,e   Davies, Alun H ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BONN   (Germany)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

chronic venous disease; education; healthcare burden; post thrombotic syndrome; Varicose veins

Indexed keywords

ACCREDITATION; CHRONIC VEIN INSUFFICIENCY; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; EDEMA; EUROPE; EVIDENCE BASED PRACTICE; HUMAN; LOWER EXTREMITY DEEP VEIN THROMBOSIS; LUNG EMBOLISM; MEDICAL CARE; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MEDICAL RESEARCH; MEDICAL SOCIETY; MINIMALLY INVASIVE PROCEDURE; PHLEBOLOGY; PHYSICIAN; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; RECURRENT DISEASE; REIMBURSEMENT; REVIEW; RISK REDUCTION; TELANGIECTASIA; ULCER; VARICOSIS; VEIN DISEASE; ANGIOPLASTY; ANTICOAGULANT THERAPY; BLEEDING; BLOOD CLOT LYSIS; CERTIFICATION; COMPRESSION BANDAGE; COMPRESSION STOCKING; COMPRESSION THERAPY; EUROPEAN; HEALTH DISPARITY; MEDICAL SPECIALIST; PATHOPHYSIOLOGY; PHLEBITIS; POPULATION; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESOURCE MANAGEMENT; SCLEROTHERAPY; SURGICAL THROMBECTOMY; VASCULAR STENT; VASCULAR SURGERY; VENOUS REFLUX;

ANTICOAGULANT AGENT;

EID: 84901007860     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1177/0268355514527046     Document Type: Review

References (21)

1. Beebe-Dimmer JL,Pfeifer JR,Engle JS,Schottenfeld D.The epidemiology of chronic venous insufficiency and varicose veins.Annals of epidemiology. 2005;15:175-84.
2. White RH.The epidemiology of venous thromboembolism.Circulation. 2003;107:I4-8.
3. Carradice D,Mazari FA,Samuel N,Allgar V,Hatfield J,Chetter IC.Modelling the effect of venous disease on quality of life.The British journal of surgery. 2011;98:1089-98.
4. Kahn SR,Shbaklo H,Lamping DL,Holcroft CA,Shrier I,Miron MJ, et al.Determinants of health-related quality of life during the 2 years following deep vein thrombosis.Journal of thrombosis and haemostasis. 2008;6:1105-12.
5. Casey ET,Murad MH,Zumaeta-Garcia M,Elamin MB,Shi Q,Erwin PJ, et al.Treatment of acute iliofemoral deep vein thrombosis.Journal of vascular surgery. 2012;55:1463-73.
6. Gloviczki P,Comerota AJ,Dalsing MC,Eklof BG,Gillespie DL,Gloviczki ML, et al.The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.Journal of vascular surgery. 2011;53:2S-48S.
7. Eklof B,Rutherford RB,Bergan JJ,Carpentier PH,Gloviczki P,Kistner RL, et al.Revision of the CEAP classification for chronic venous disorders: consensus statement.Journal of vascular surgery. 2004;40:1248-52.
8. Maurins U,Hoffmann BH,Losch C,Jockel KH,Rabe E,Pannier F.Distribution and prevalence of reflux in the superficial and deep venous system in the general population-results from the Bonn Vein Study, Germany.Journal of vascular surgery. 2008;48:680-7.
9. Chiesa R,Marone EM,Limoni C,Volonte M,Schaefer E,Petrini O.Chronic venous insufficiency in Italy: the 24-cities cohort study.European journal of vascular and endovascular surgery. 2005;30:422-9.
10. Bihari I,Tornoci L,Bihari P.Epidemiological study on varicose veins in Budapest.Phlebology. 2012;27:77-81.
11. Moore HM,Lane TR,Thapar A,Franklin IJ,Davies AH.The European burden of primary varicose veins.Phlebology. 2013;28:141-7.
12. College voor zorgverzekeringen. Summary (New) techniques and treatment for varicose veins. Netherlands: CVZ; 2010.
13. Edwards AG,Baynham S,Lees T,Mitchell DC.Management of varicose veins: a survey of current practice by members of the Vascular Society of Great Britain and Ireland.Annals of the Royal College of Surgeons of England. 2009;91:77-80.
14. Marsden G,Perry M,Kelley K,Davies AH.Diagnosis and management of varicose veins in the legs: summary of NICE guidance.BMJ. 2013;347:f4279-f4279.
15. Baldwin MJ,Moore HM,Rudarakanchana N,Gohel M,Davies AH.Post-thrombotic syndrome: a clinical review.Journal of thrombosis and haemostasis. 2013;11:795-805.
16. Enden T,Haig Y,Klow NE,Slagsvold CE,Sandvik L,Ghanima W, et al.Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.Lancet. 2012;379 (9810): 31-8.
17. Enden T,Resch S,White C,Wik HS,Klow NE,Sandset PM.Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis.Journal of thrombosis and haemostasis: JTH. 2013;11 (6): 1032-42.
18. Grommes J,Strijkers R,Greiner A,Mahnken AH,Wittens CH.Safety and feasibility of ultrasound-accelerated catheter-directed thrombolysis in deep vein thrombosis.European journal of vascular and endovascular surgery. 2011;41:526-32.
19. Parsi K,Zimmet S,Allegra C,Bergan J,Gasparis AP,Labropoulos N, et al.Phlebology training curriculum. A consensus document of the International Union of Phlebology (UIP)-2010.International angiology. 2010;29:533-59.
20. van Bockel JH,Bergqvist D,Cairols M,Liapis CD,Benedetti-Valentini F,Pandey V, et al.Education in vascular surgery: critical issues around the globe-training and qualification in vascular surgery in Europe.Journal of vascular surgery. 2008;48:69S-75S.
21. Thibault PK.The Australasian College of Phlebology and its role.Phlebology. 2009;24:191-2.